Cellectis S.A.
CLLS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $285,926 | $153,497 | $124,194 | $180,169 |
| - Cash | $52,243 | $59,809 | $127,636 | $143,251 |
| + Debt | $37,583 | $94,773 | $91,768 | $91,461 |
| Enterprise Value | $271,266 | $188,461 | $88,326 | $128,379 |
| Revenue | $35,172 | $16,725 | $10,655 | $12,717 |
| % Growth | 110.3% | 57% | -16.2% | – |
| Gross Profit | $32,815 | $14,300 | $8,640 | $10,202 |
| % Margin | 93.3% | 85.5% | 81.1% | 80.2% |
| EBITDA | $7,707 | -$16,664 | -$11,285 | $14,174 |
| % Margin | 21.9% | -99.6% | -105.9% | 111.5% |
| Net Income | $589 | -$23,735 | -$18,128 | $5,922 |
| % Margin | 1.7% | -141.9% | -170.1% | 46.6% |
| EPS Diluted | 0.006 | -0.24 | -0.18 | 0.059 |
| % Growth | 102.5% | -33.3% | -404.1% | – |
| Operating Cash Flow | -$1,571 | -$10,310 | -$17,160 | -$47 |
| Capital Expenditures | -$1,181 | -$305 | -$395 | -$1,745 |
| Free Cash Flow | -$2,752 | -$10,615 | -$17,555 | -$1,792 |